AP2000001926A0 - Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. - Google Patents

Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.

Info

Publication number
AP2000001926A0
AP2000001926A0 APAP/P/2000/001926A AP2000001926A AP2000001926A0 AP 2000001926 A0 AP2000001926 A0 AP 2000001926A0 AP 2000001926 A AP2000001926 A AP 2000001926A AP 2000001926 A0 AP2000001926 A0 AP 2000001926A0
Authority
AP
ARIPO
Prior art keywords
voacamine
malarial agent
malarial
agent containing
pescheria
Prior art date
Application number
APAP/P/2000/001926A
Inventor
Silvio Rossi
Motta Guiseppe Bertelli
Original Assignee
Millenia Hope Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millenia Hope Inc filed Critical Millenia Hope Inc
Publication of AP2000001926A0 publication Critical patent/AP2000001926A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention concerns voacamine as anti-malarial agent active against plasmodium falciparum strains, including the resistant strains, as well as an anti-malarial agent containing as main active principle voacamine. A basic pescheria extract, in particular pescheria fuchsiaefolia, can be used as anti-malarial agent having in particular voacamine as active principle.
APAP/P/2000/001926A 1998-03-26 1999-03-25 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. AP2000001926A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98TO000264A ITTO980264A1 (en) 1998-03-26 1998-03-26 APPLICATION OF A NON-QUATERNARY BASIC EXTRACT OF FUCHSIAEFOLIA PESCHIERA WITH ANTI-MALARICA ACTIVITY
PCT/IB1999/000524 WO1999048501A1 (en) 1998-03-26 1999-03-25 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine

Publications (1)

Publication Number Publication Date
AP2000001926A0 true AP2000001926A0 (en) 2000-09-30

Family

ID=11416637

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2000/001926A AP2000001926A0 (en) 1998-03-26 1999-03-25 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.

Country Status (10)

Country Link
EP (1) EP1067938A1 (en)
JP (1) JP2002507570A (en)
AP (1) AP2000001926A0 (en)
AU (1) AU2742799A (en)
BR (1) BR9909153A (en)
CA (1) CA2325879A1 (en)
IT (1) ITTO980264A1 (en)
OA (1) OA11491A (en)
WO (1) WO1999048501A1 (en)
ZA (1) ZA200006020B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812199A1 (en) * 2000-07-31 2002-02-01 Maximun Frederic Yanze Effervescent antimalarial compositions containing chloroquine, optionally other active agents, effervescent couple and taste modifiers, is dissolved in water to give a pleasant tasting solution for oral administration
EP1491197A1 (en) * 2003-06-26 2004-12-29 Bertelli Motta, Guiseppe Pharmaceutical composition comprising voacamine for the stimulation and modulation of the human immunologic system
US20070232588A1 (en) * 2004-09-15 2007-10-04 Leonard Stella Anti-parasitic and/or anti-viral and/or anti-microbial compositions
US20070032460A1 (en) * 2005-08-04 2007-02-08 Leonard Stella Use of voacamine and related compounds in the treatment of malaria
CA2624750C (en) 2005-10-04 2012-01-03 The Director General, Defence Research And Development Organisation Anti-malarial compound isolated from gomphostemma niveum
EP1958638A1 (en) 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
KR101440073B1 (en) 2011-11-28 2014-09-18 연세대학교 산학협력단 Pharmaceutical Compositions Comprising Plant-Derived Natural Compounds Having Anti-angiogenic Activities
JP2016508979A (en) * 2012-12-20 2016-03-24 デメレックス， インコーポレイテッド Substituted norbogaine
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR20220008824A (en) 2019-04-17 2022-01-21 컴퍼스 패쓰파인더 리미티드 How to treat anxiety disorders, headache disorders and eating disorders with psilocybin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823204A (en) * 1956-03-30 1958-02-11 Gobey Lab Alkaloids of voacanga

Also Published As

Publication number Publication date
WO1999048501A9 (en) 2000-03-16
ITTO980264A1 (en) 1999-09-26
JP2002507570A (en) 2002-03-12
AU2742799A (en) 1999-10-18
WO1999048501A1 (en) 1999-09-30
ZA200006020B (en) 2001-06-25
EP1067938A1 (en) 2001-01-17
BR9909153A (en) 2000-11-14
CA2325879A1 (en) 1999-09-30
OA11491A (en) 2004-05-07

Similar Documents

Publication Publication Date Title
MX265024B (en) Novel surfactants and formulations.
ZA200205557B (en) 4-Aminopicolinates and their use as herbicides.
TR200202194T2 (en) Polyglutamic acid-camptothecin compounds and preparation methods
MXPA03004644A (en) Phenylacetamido- pyrazole derivatives and their use as antitumor agents.
MXPA03005275A (en) Prevention of preservative uptake into biomaterials.
WO2002076499A3 (en) Combination treatment of pancreatic cancer
AU4347701A (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
AP2000001926A0 (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.
MX245674B (en) Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase.
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
HK1048318A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors.
AU2002213882A1 (en) Attenuated hiv strains and use thereof
ZA200203163B (en) Lockable drill steel and chuck assembly.
HK1054037A1 (en) 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
HK1045813A1 (en) Non-solid composition for local application comprising glycerol and alchemilla vulgaris extract.
CA98129S (en) Storage case
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
HK1047047B (en) Water-soluble trioxanes as potent and safe antimalarial agents
AU3956502A (en) Saframycins, analogues and uses thereof
ZA997490B (en) High hardness and strength sintered body.
MXPA04002104A (en) Antibodies against caspase-8, their preparation and use.
MY129761A (en) Ortho-phenylphenolate concentrates
MD1473G2 (en) Antiherpetic remedy
IL154297A0 (en) Glycoproteins, their preparation and use
ZA200201384B (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one.